Table 8.
Relationship of the Apo C111 Genotype with the Lipid Spectrum in the Uighurs with Coronary Heart Disease (CHD)
| Parameters | SISI | SIS2 | S2S2 | P1 | P2 | P3 |
|---|---|---|---|---|---|---|
| (mmol/l) | (n =39) | (n = 35) | (n = 5) | |||
| TC (mmol/l) | 5.64±0.12 | 5.63±0.14 | 5.60±0.27 | > 0,05 | > 0,05 | > 0,05 |
| HDLC | 1.18±0.03 | 1.17±0.04 | 1.15±0.09 | > 0,05 | > 0,05 | > 0,05 |
| TG | 1.6±0.08 | 2.3±0.07 | 2.6±0.15 | < 0,05 | < 0,05 | >0,05 |
| LDLC | 4.14±0.12 | 4.0±0.14 | 3.93±0.27 | > 0,05 | > 0,05 | > 0,05 |
| VLDLC | 0.32±0.03 | 0.46±0.02 | 0.52±0.02 | <0,05 | <0,05 | >0,05 |
| AI (relative unit) | 3.78±0.16 | 3.81±0.18 | 3.87±0.33 | > 0,05 | > 0,05 | > 0,05 |
| Apo A1 (mg/dl) | 128.2±2.79 | 129.1±2.90 | 130.0±4.56 | > 0,05 | > 0,05 | > 0,05 |
| Apo B (mg/dl) | 89.79±2.73 | 90.29±2.94 | 88.27±4.82 | > 0,05 | > 0,05 | > 0,05 |
| Apo E (mg/dl) | 4.0±0.12 | 3.98±0.15 | 3.87±0.54 | > 0,05 | > 0,05 | > 0,05 |
Note: P1 – Statistical differences of lipid parameters in patients with the SISI and SIS2 genotypes, P2 – Statistical differences of lipid parameters in patients with the SISI and S1S2 genotypes, P3 – Statistical differences of lipid parameters in patients with the SIS2 and S2S2 genotypes.